- Round ID
- FR-00328
- Stage
- Series B
- Round name
- Series B
- Amount
- $2.1B
Dated funding evidence
Isomorphic Labs
Series B · $2.1B · 2026-05-12
Reported round$2.1BSeries B
- Disclosure date
- 2026-05-12
- Reported currency
- USD
- Companies House
- 13223825
- Evidence sources
- 4
Company
Isomorphic LabsCH 132238252026-05-12Series B$2.1B
Resolved investor records
Thrive CapitalLead investorAlphabetInvestorGVInvestorMGXInvestorTemasekInvestorCapitalGInvestorUK Sovereign AI FundInvestor
Investor links inherit this round’s named source and date. Resolved links use an exact canonical investor name; unresolved names remain unlinked.
Record fields
What the source states
Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.
- Lead investors
- Thrive Capital
- Other investors
- Alphabet, GV, MGX, Temasek, CapitalG, UK Sovereign AI Fund
- Source layers
- VC research snapshot, Live Chris T D1
- Snapshot
- 2026-08-25
Named evidence
Source trail
This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.